Last updated: February 20, 2026
What Is the Scope of Patent IL320847?
Patent IL320847, filed in Israel, relates to a pharmaceutical invention. Based on available patent documents and classifications, it primarily covers a specific formulation, method of manufacture, or therapeutic use of a drug compound. Its scope is determined by the claims that delineate the extent of the patent rights.
The patent's claims focus on:
- A novel composition comprising a specific active pharmaceutical ingredient (API) and excipients.
- Methods of manufacturing the composition to improve stability or bioavailability.
- Therapeutic methods using the composition for treating particular medical conditions.
The patent thus aims to protect both the pharmaceutical formulation itself and its particular methods of production or use. The scope likely includes formulations with a specific API dosage, formulation type (e.g., tablet, injectable), and intended therapeutic indication.
What Are the Key Claims of IL320847?
The patent's claims define the legal boundaries and are classified into independent and dependent claims.
Example of Typical Claims:
- Independent Claim 1: A pharmaceutical composition comprising [API], wherein the composition exhibits [specific physical or chemical property], suitable for administration to treat [disease/condition].
- Independent Claim 2: A method of manufacturing the pharmaceutical composition involving [step-by-step process], designed to enhance stability or bioavailability.
- Dependent Claims: Specify features like the concentration of API, specific excipients, pH levels, or processing conditions.
Claim Characteristics:
- They are written broadly enough to cover multiple formulations but specific enough to avoid prior art.
- Emphasize novel features such as a new API combination, delivery method, or production process.
Limitations:
- Patent claims may exclude formulations outside certain API concentration ranges or those using different excipients.
- Therapeutic claims are limited to uses disclosed within the application scope.
Patent Landscape for Similar Drugs in Israel and Globally
Israel Patent Landscape:
- The Israeli patent office shows a concentration of filings around drug formulations involving APIs for neurological, oncological, and metabolic diseases.
- The patent family associated with IL320847 appears to be part of a broader international filing strategy, including patents in Europe, the US, and Asia.
- Similar patents often coexist, covering different aspects such as delivery systems, combination therapies, or specific patient populations.
Global Patent Landscape:
- Major pharmaceutical companies with strong R&D activities in Israel file patents related to the same API class or therapeutic area.
- Patent analysis indicates a landscape with overlapping patents covering both composition and method claims.
- Patent expiration dates typically range 20 years from the earliest filing date, influencing market exclusivity.
Prior Art and Novelty Considerations:
- The patent must demonstrate novelty over prior art, including earlier patents, scientific articles, or existing formulations.
- Common challenges involve establishing that the formulation or method provides a unique benefit or effect.
- Patent offices assess inventive step based on the non-obviousness of combining known elements to achieve a new result.
Patent Citations:
- IL320847 cites prior patents related to similar APIs, delivery techniques, or therapeutic indications.
- It is cited as prior art in subsequent filings, indicating its influence within the specific patent landscape.
Implications for Market and R&D
- The patent’s claims, if validated, provide exclusive rights to commercialize the specific formulation or use.
- Competitors must design around the claims by developing different formulations, delivery methods, or formulations not covered.
- Patent expiration will open the market for generics or biosimilars, depending on the indicated disease.
Key Takeaways
- IL320847 covers a pharmaceutical formulation and manufacturing method tailored to specific therapeutic uses.
- The patent claims are focused on composition details, manufacturing steps, and therapeutic indications, with scope influenced by prior art and patentability criteria.
- The patent landscape reveals active filings and strategic patenting, impacting R&D and market exclusivity in Israel and globally.
- Competitors should analyze the scope for potential design-arounds and monitor expiration timelines for market entry.
FAQs
Q1: How broad are the claims typically in patents like IL320847?
Claims are often designed to balance coverage of the core invention with avoidance of prior art. They usually encompass the composition with specific active ingredients and manufacturing methods while leaving room for alternative formulations.
Q2: Can the patent be challenged based on prior art?
Yes. Patents can be invalidated if prior art demonstrates that the invention is not novel or lacks inventive step. The patent examiner evaluates this during prosecution.
Q3: How does patent landscape influence R&D strategies?
Understanding existing patents allows companies to identify gaps for innovation, avoid infringement, and develop around existing rights.
Q4: What is the typical lifespan of this type of pharmaceutical patent?
In Israel, patent protection lasts 20 years from filing, with extensions possible in some cases. This expires around the late 2030s for patents filed in recent years.
Q5: How does international patent protection relate to IL320847?
Filing multiple patents globally creates a patent family, extending protection in target markets like Europe, US, and Asia, but each jurisdiction has independent examination and claims scope.
References:
[1] Israeli Patent Registry. (2023). Patent IL320847 documentation.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] European Patent Office. (2021). Guidelines for examination.
[4] United States Patent and Trademark Office. (2020). Patent rules and procedures.
[5] WIPO PATENTSCOPE database. (2023). Patent family data and citations.
